Schwarz Dygos Wheeler Investment Advisors LLC Novo Nordisk A S Transaction History

Schwarz Dygos Wheeler Investment Advisors LLC

$399 Million
Q4 2024

A detailed history of Schwarz Dygos Wheeler Investment Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Schwarz Dygos Wheeler Investment Advisors LLC holds 8,921 shares of NVO stock, worth $729,648. This represents 0.19% of its overall portfolio holdings.

Number of Shares

8,921

Previous 9,461 5.71%

Holding current value

$729,648

Previous $1.13 Million 31.88%

% of portfolio

0.19%

Previous 0.29%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$85.0 - $120.04 $45,900 - $64,821	-540 Reduced 5.71%	8,921 $767,000
Q3 2024 Nov 08, 2024	SELL	$119.07 - $145.42 $78,109 - $95,395	-656 Reduced 6.48%	9,461 $1.13 Million
Q2 2024 Aug 02, 2024	BUY	$122.71 - $146.91 $2,331 - $2,791	19 Added 0.19%	10,117 $1.44 Million
Q1 2024 May 03, 2024	BUY	$102.11 - $135.92 $510 - $679	5 Added 0.05%	10,098 $1.3 Million
Q4 2023 Feb 02, 2024	SELL	$87.78 - $105.45 $23,700 - $28,471	-270 Reduced 2.61%	10,093 $1.04 Million
Q3 2023 Nov 03, 2023	BUY	$90.94 - $199.54 $470,796 - $1.03 Million	5,177 Added 99.83%	10,363 $942,000
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $531,735 - $588,563	-3,409 Reduced 39.66%	5,186 $839,000
Q1 2023 Apr 27, 2023	BUY	$132.34 - $159.14 $13,234 - $15,913	100 Added 1.18%	8,595 $1.37 Million
Q3 2022 Nov 04, 2022	BUY	$95.28 - $116.93 $9,528 - $11,693	100 Added 1.19%	8,495 $846,000
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $91,703 - $110,851	985 Added 13.29%	8,395 $932,000
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $28,955 - $35,358	302 Added 4.25%	7,410 $830,000
Q3 2021 Oct 21, 2021	SELL	$84.42 - $106.62 $10,636 - $13,434	-126 Reduced 1.74%	7,108 $682,000
Q2 2021 Jul 28, 2021	BUY	$67.66 - $84.76 $20,974 - $26,275	310 Added 4.48%	7,234 $606,000
Q2 2020 Jul 15, 2020	BUY	$58.54 - $67.94 $7,844 - $9,103	134 Added 1.97%	6,924 $451,000
Q4 2019 Jan 09, 2020	BUY	$49.86 - $58.26 $24,930 - $29,130	500 Added 7.95%	6,790 $393,000
Q3 2019 Nov 15, 2019	SELL	$47.54 - $53.43 $11,885 - $13,357	-250 Reduced 3.82%	6,290 $325,000
Q2 2019 Nov 15, 2019	BUY	$46.79 - $52.47 $1,169 - $1,311	25 Added 0.38%	6,540 $334,000
Q4 2018 Nov 15, 2019	BUY	$41.54 - $47.25 $270,633 - $307,833	6,515 New	6,515 $300,000

Others Institutions Holding NVO

# of Institutions

1,860

Shares Held

333M

Call Options Held

6.55M

Put Options Held

7.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $185B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwarz Dygos Wheeler Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schwarz Dygos Wheeler Investment Advisors LLC with notifications on news.

Account

Schwarz Dygos Wheeler Investment Advisors LLC Novo Nordisk A S Transaction History